Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins.
about
Primary mediastinal B-cell lymphoma: treatment and therapeutic targetsGray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France.Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do?Primary mediastinal large B-cell lymphoma.The biology of human lymphoid malignancies revealed by gene expression profiling.Primary mediastinal lymphoma: diagnosis and treatment options.Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.Pathobiology of primary mediastinal B-cell lymphoma.Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival.Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.Mechanisms of B-cell lymphoma pathogenesis.Gray zone lymphomas.Nodal aggressive B-cell lymphomas: a diagnostic approachSelective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results.Primary mediastinal B-cell lymphoma: detection of BCL2 gene rearrangements by PCR analysis and FISHCommentary on the WHO classification of tumors of lymphoid tissues (2008): "Gray zone" lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma.Inflammation and immune system activation in aging: a mathematical approach.Primary mediastinal lymphomas, their morphological features and comparative evaluationPrimary mediastinal DLBCL: evolving biologic understanding and therapeutic strategies.Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?Structural genomic alterations in primary mediastinal large B-cell lymphoma.IV. Masses in the mediastinum: primary mediastinal lymphoma and intermediate types.Identification of a chemokine receptor profile characteristic for mediastinal large B-cell lymphoma.Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH).The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome.Mediastinal Gray Zone Lymphoma: A Wider Category Than We Think?Mediastinal gray zone lymphoma.How do we define Hodgkin's disease? The authors' reply.Large B-cell lymphoma with Hodgkin's features.Prognostic impact of MUM1 expression by immunohistochemistry on primary mediastinal large B-cell lymphoma.Aberrant somatic hypermutation and expression of activation-induced cytidine deaminase mRNA in mediastinal large B-cell lymphoma.High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.Brentuximab vedotin: clinical updates and practical guidance.
P2860
Q28278652-39754A6F-1475-4474-BFE3-60C0397C3B07Q33560762-E33B89B8-C40E-413B-9E0C-D478CBCB53D8Q34185759-12C6181F-36E6-43C4-B80D-D7722CF0EB0BQ34266819-2241FA5C-7144-42CE-BAEF-24183369EA49Q34313320-FA0D9280-6DAF-4061-8BD2-AE3A43E3F8C5Q34455499-3D4318DB-99DB-4871-A62D-B8C6C14BC300Q34802443-BFA796EF-3337-4882-91F2-6F3A200CACC3Q35564769-AF0AB8D8-2CFA-4364-9E5B-FC3C5E8422C9Q35808376-8B59878B-9521-4732-B1F2-F52DE771CAD8Q35849831-191E79FD-578C-49A3-BB5D-16E22C69365CQ36057764-8CDBA1FA-C19C-4E8E-9E5E-AF596528EB40Q36085626-8FE685A2-EB35-4B23-8677-5F0FB2BF1613Q36270065-184CC94F-4FCD-43E5-A064-4F762706DDABQ36763463-E5C1A405-50F4-44AA-BE90-747A205A44A6Q37195045-F164C7E3-F4AE-4D22-8D06-4E577244342EQ37269004-66DA7C97-7119-4B9D-88F4-A7587E28D453Q37301300-3BD54BB5-5D7C-4387-9C9B-AD82C5E076ADQ37322037-03361352-0123-48B1-A82F-F62EF3C4AFEDQ37584966-D9084B9C-3A39-4504-B9E3-E1FDE179B267Q37905667-DCA5C590-8B27-4EFB-A0A0-17B9965A7DA8Q38029564-279C7265-3264-4CD9-A40B-C30B753EFCCFQ38267888-852F6B45-E470-4A45-82BF-C4031DEC56EDQ38523971-4A25EACE-61E0-4493-A666-13EC896AA738Q39836435-A61A1917-BA87-4007-9AF5-2998A3EA231BQ40087598-F99E8E66-8834-4D09-BA5B-CDD7DE01E619Q40649778-B8BE3368-7346-473B-930E-2B941162B515Q40864458-BE2DADBD-510B-441B-B33A-FF41F0DD5E67Q42708644-C5BD7213-8683-4039-A5D5-4C114C5233FEQ43011229-1A1144A5-6131-47F7-81F3-297274B05725Q43428745-4C8B2FCC-BCA7-4FCE-8996-6CA958DEDB3CQ45124110-B0AD8A71-52F0-4C4F-83AE-EF7FEBA1B43EQ46447362-477C5CBD-005B-493C-8030-6F557E0990DEQ48890862-53C4B7DC-D343-4975-89A5-A64B0D945785Q49282959-5F1FEA6F-1760-4691-B31D-11BAF956F2FE
P2860
Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Primary mediastinal B-cell lym ...... he absence of immunoglobulins.
@ast
Primary mediastinal B-cell lym ...... he absence of immunoglobulins.
@en
type
label
Primary mediastinal B-cell lym ...... he absence of immunoglobulins.
@ast
Primary mediastinal B-cell lym ...... he absence of immunoglobulins.
@en
prefLabel
Primary mediastinal B-cell lym ...... he absence of immunoglobulins.
@ast
Primary mediastinal B-cell lym ...... he absence of immunoglobulins.
@en
P2093
P2860
P50
P1476
Primary mediastinal B-cell lym ...... he absence of immunoglobulins.
@en
P2093
Brunangelo Falini
Domenico Novero
Edoardo Pescarmona
Elena Sabattini
Federica Pieri
Franco Cavalli
Milena Piccioli
Peter W M Johnson
Philippe Gaulard
P2860
P304
P356
10.1016/S0002-9440(10)63815-1
P407
P577
2003-01-01T00:00:00Z